Appraisal of icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides [ID3831] 6.1. Intoduction by the Chair, Professor Stephen O'Brien– Part 1 only (open session) 6.2. Declaration of interests – Part 1 only (open session) 6.3. Presentation by the Chair– Part 1 AND part 2 (open and closed session) 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD)– Part 2 only (closed session)
Any idea when we get the final decision ...that day ?